Please select from the following:

Tuition Fee
Hostel Fee

Close

Faculty Detail

  1. Home
  2. Faculty
  3. DR. SUNU LAZAR CYRIAC

DR. SUNU LAZAR CYRIAC

Reg.No: TCMC 29434
Professor
Area of Interest

Precision Oncology (Targeted Therapy and Molecular methods

Bone Marrow Transplantation

Cell therapy (CAR-T, TILS etc)

Hemato-Oncology

Affordable cancer care

Clinical Trials and clinical research

Gynec Medical Oncology

Gastro-Intestinal Medical Oncology

Adolescent and Young Adults cacner care

Co-operative networks in clinical research

 

Qualification Specialization Institution Year of Passing
DM Medical Oncology AIIMS-New Delhi 2013
Fellowship Gynecology & Drug Development Program PMH-Toronto 2018
Fellowship BMT PMH-Toronto 2019
Designation Institution Tenure
Assistant Professor Amala Institute of Medical Sciences,Thrissur 2019 to 2021
Assistant Professor JIPMER 2014-2016
Associate Professor Amala Institute of Medical Sciences,Thrissur 2021 Onwards
HOD BMT and Cell therapy Unit, Amala Institute of Medical Sciences,Thrissur 2020 Onwards
HOD Molecular Oncology Lab, Amala Institute of Medical Sciences,Thrissur 2023 Onwards
HOD Clinical Research Unit, Amala Institute of Medical Sciences,Thrissur 2020 Onwards
HOD Amala Wings, Amala Institute of Medical Sciences,Thrissur 2020 Onwards
  • No family should suffer from cervical cancer twice – the palliative care role in HPV prevention; Iyengar S, Kantor K, Cyriac S, Remadevi K, Usha V, Robinson S, Rani A, Rajagopal MR, Broderick A.J Pain Symptom Manage. 2021 Jul 10;S0885-3924(21)00420-6
  • Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in Myelofibrosis;Sunu Cyriac, Shruti Prem, AuroViswabandya et al; Eur J Haematol. 2021 Jul 14. doi:10.1111/ejh.13689. Online ahead of print
  • Research Biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions and preferences; AinhoaMadariaga, Sunu Cyriac,Amit M. Oza, Stephanie Lheureux,doi.org/10.1016/j.ajog.2021.06.071; Available online 23 June 2021
  • HPV vaccine: Expanding indications and global disparity. Christina Uwins, Sunu Cyriac, GeetuBhandoria; Vaccine2021 Jun 29;39(29):3787-3789
  • Retrospective Analysis of Early Impact of COVID-19 on Systemic Cancer Treatment—A Pilot Study; Sunu L Cyriac, AnakhaPattiyeil, Febin Antony. Indian Journal of Medical and Paediatric Oncology 2021; 42(01): 015-020; DOI: 10.1055/s-0041-1730239
  • Updates on systemic therapy for cervical cancer (invited review-accepted for publication in Gynecology and breast cancer special edition, Jan 2021). Cyriac S,Gopu P, Antony F, Oza A M, KarakasisK; Ind J Med ResJan 2021
  • Knowledge, Attitude and Practice of Indian Oncology Residents on Clinical Trials: An Observational StudyRanjith Kumar CS*, SmitaKayal, Biswajit Dubashi,Cyriac S et al. J cancer Clin Trials;Volume 5:3, 2020
  • Delivery of Cancer Care in India and Canada: Opportunities for Bidirectional Learning, Cyriac S, Booth CM. J Glob Oncol. 2019 Oct;5:1-5
  • Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions.Pillai US, Kayal S, Cyriac S, Nisha Y, Dharanipragada K, Kamalanathan SK, Halanaik D, Kumar N, Madasamy P, Muniswamy DK, Dubashi B. Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2673-2679
  • Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O'Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S. J Oncol Pract. 2019 Dec;15(12):e1066-e1075
  • POEMS Syndrome: Indian Experience From a Tertiary-Care Institute; Pramanik A, S Cyriac, L Kumar et al, Clin Lymphoma Myeloma Leuk. 2019 May 29. pii: S2152-2650(19)30062-X
  • S Panda, S Cyriac, B Dubashi et al, Adolescent and Young Adults with Gastric Cancer (AYA-GC)—The Dilemma of an Under-Represented Group: A Multi-Institutional Analysis from the Indian Subcontinent; South Asian J Can 2023; 01:1-92|e1; DOI 10.1055/s-0043-177127

    https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0043-1771275

  • S Cyriac, A Garcia-Horton, , J Mattsson, FV Michelis et al; Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups; Eur J Haematol, 2022 Aug 26 DOI: 10.1111/ejh.13850
  • Sunu Cyriac, Varun Narayan; Marked New Bone Formation on Treatment of Multiple Myeloma; Mayo Clin Proc, 2022; doi: 10.1016/j.mayocp. 2022.03.002
  • Al-Shaibani E, Cyriac S, Michelis Fotios V, et al; Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia; Clin Lymphoma Myeloma Leuk. 2021 Jun. doi: 10.1016/j.clml.2021.01.022
  • Cyriac S, Katherine Karakasis, Amit M. Oza; Rucaparib for the treatment of ovarian cancer; Expert Opinion on Orphan Drugs Vol 6, 2018 - Issue 2
  • Cyriac S, Amit M. Oza, K Karakasis; DNA Repair Defects for Therapy in Ovarian Cancer: The BRCA1/ 2 and PARP Inhibitor Story; Ind J Gynec Oncol 2017 Doi 10.1007/s40944-017-0155-8
  • Rajagopal MD, Kar R, Basu D, Cyriac SL et al; Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls; Ind J Pathol Micro. 2017;doi: 10.4103/IJPM.IJPM_139_16
  • Pillai, U, Cyriac, S, Badhe, B. et al; Impact of Oncologist Initiated Selective Review of Pathology Specimens in Multidisciplinary Onco-pathological Discussions on the Management of Malignancies in a University Hospital in India; J of Adv in Med and Medical Res 2016 https://doi. org /10. 9734/BJMMR/2016/27156
  • Ramakrishnaiah VP , Kotlapati S, Cyriac S et al; Palliation of Dysphagia in Carcinoma Esophagus, Clin Med Insights Gastroenterol 2016; doi: 10.4137/CGast.S30303
  • Jain D, Cyriac S, Mathur SR, Kumar L, Guleria R et al; Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study; Ind J Med Res. 2016. doi: 10.4103/0971-5916.182621
  • Dhanraj KM, Kayal S, Cyriac S. et al; Comparison of efficacy of neoadjuvant chemotherapy FEC 100 and Docetaxel 75 versus AC and Docetaxel in locally advanced breast cancer: a randomized clinical study; Med Oncol 2015 Dec; doi: 10.1007/s12032-015-0697-5
  • Cyriac S, Walia R, Suri V, Bakhshi S; Colonic Malignant Peripheral Nerve Sheath Tumor in a Child; J Ped Hemat/Oncol: Nov 2014; doi: 10.1097/ MPH.0b013e318290bc9f
  • Kayal S, Sharma A, Tejomurtula T, Cyriac S, Raina V. et al; High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: A Single Institution Experience at All India Institute of Medical Sciences, New Delhi, Using Non-Cryopreserved Peripheral Blood Stem Cells. Clin Lymp Myel Leuk. 2014. Doi:10.1016/j.clml.2013.09.001
  • Kumar L, Cyriac S, Sharma O, et al; Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors; Clin Lymp Myel Leuk 2013; doi:10.1016/j.clml.2012.08.007
  • Gauri Kapoor, Sunu Lazar Cyriac, V P Gangadharan, Prashant Mathur et al; Profile of Childhood Cancers From Hospital-Based Cancer Registries in India, 2012-19; Indian Pediatr. 2024 Jan 15;61(1):39-44.